Association of resistance to activated protein C and dural arteriovenous fistulas

J A Kraus1, B K Stüper, P Berlit

  • 1Department of Neurology, Alfried-Krupp Hospital, Essen, Germany.

Journal of Neurology
|November 10, 1998
PubMed

Insights

The Factor V Leiden mutation, a common cause of blood clots, was found in three out of seven patients with dural arteriovenous fistulas (DAVFs). This suggests a potential link between this genetic mutation and the development of DAVFs.

Area of Science:

  • Neuroscience
  • Genetics
  • Hematology

Background:

  • Activated protein C resistance (APCR) is the most common genetic risk factor for venous thrombosis.
  • FV Leiden mutation is the primary cause of APCR.
  • Dural arteriovenous fistulas (DAVFs) are linked to cerebral venous thrombosis.

Purpose of the Study:

  • To investigate the prevalence of the FV Leiden mutation in patients diagnosed with DAVFs.
  • To explore the potential role of FV Leiden in the pathogenesis of DAVFs.

Main Methods:

  • APCR ratio determination using standard procedures.
  • Mutation analysis for FV Leiden via reverse hybridization assay in patients with pathological APCR ratios (less than 2.0).

Main Results:

  • Three out of seven patients with DAVFs exhibited pathological APCR ratios.
  • These three patients were found to be heterozygous for the FV Leiden mutation.

Conclusions:

  • The study hypothesizes that the FV Leiden mutation may contribute to the development of DAVFs.
  • Further research is warranted to confirm the association between FV Leiden and DAVF pathogenesis.